1. Home
  2. GSK
  3. GSK News

Latest GSK plc (Each representing two) (GSK) News on February 22, 2025

GSK’s Sluggish Shares Seen at Risk of New Activist Campaign
GSK

Bloomberg

a day ago

GSK’s Sluggish Shares Seen at Risk of New Activist Campaign

FDA Approves GSK's 5-in-1 Meningococcal Vaccine For Adolescents Ahead Of CDC Advisory Committee Vote Meeting Next Week (UPDATED)
GSK

Benzinga

3 days ago

FDA Approves GSK's 5-in-1 Meningococcal Vaccine For Adolescents Ahead Of CDC Advisory Committee Vote Meeting Next Week (UPDATED)

PENMENVY, GSK’s 5-in-1 Meningococcal Vaccine, Approved by US FDA to Help Protect Against MenABCWY
GSK

Business Wire

5 days ago

PENMENVY, GSK’s 5-in-1 Meningococcal Vaccine, Approved by US FDA to Help Protect Against MenABCWY

GSK

GuruFocus.com

6 days ago

GlaxoSmithKline Pharmaceuticals Ltd (BOM:500660) Q3 2025 Earnings Call Highlights: Strong ...

GSK shares shorted by leading U.S. hedge fund, The Times reports
GSK

TipRanks

7 days ago

GSK shares shorted by leading U.S. hedge fund, The Times reports

Here's Why We're Wary Of Buying GSK's (LON:GSK) For Its Upcoming Dividend
GSK

Simply Wall St.

7 days ago

Here's Why We're Wary Of Buying GSK's (LON:GSK) For Its Upcoming Dividend

GSK

Morningstar Research

9 days ago

Analyst Report: GSK plc

ViiV Healthcare and the pan-Canadian Pharmaceutical Alliance (pCPA) successfully finalize negotiations for APRETUDE for HIV-1 Pre-Exposure Prophylaxis
GSK

CNW Group

9 days ago

ViiV Healthcare and the pan-Canadian Pharmaceutical Alliance (pCPA) successfully finalize negotiations for APRETUDE for HIV-1 Pre-Exposure Prophylaxis

Some May Be Optimistic About GSK's (LON:GSK) Earnings
GSK

Simply Wall St.

10 days ago

Some May Be Optimistic About GSK's (LON:GSK) Earnings

Goldman Sachs Turns Bearish On Vaccine Maker Dynavax Amid Shingles And Hepatitis B Uncertainty
GSK

Benzinga

11 days ago

Goldman Sachs Turns Bearish On Vaccine Maker Dynavax Amid Shingles And Hepatitis B Uncertainty

Recent uptick might appease GSK plc (LON:GSK) institutional owners after losing 7.8% over the past year
GSK

Simply Wall St.

12 days ago

Recent uptick might appease GSK plc (LON:GSK) institutional owners after losing 7.8% over the past year

Bear Of The Day: GSK PLC (GSK)
GSK

Zacks

16 days ago

Bear Of The Day: GSK PLC (GSK)

Kratos Defense and GSK have been highlighted as Zacks Bull and Bear of the Day
GSK

Zacks

16 days ago

Kratos Defense and GSK have been highlighted as Zacks Bull and Bear of the Day

GSK PLC (GSK) Q4 2024 Earnings Call Highlights: Strong Specialty Medicines Drive Growth Amid ...
GSK

GuruFocus.com

16 days ago

GSK PLC (GSK) Q4 2024 Earnings Call Highlights: Strong Specialty Medicines Drive Growth Amid ...

Why GSK plc (GSK) Went Up on Wednesday
GSK

Insider Monkey

17 days ago

Why GSK plc (GSK) Went Up on Wednesday

GSK

Morningstar Research

17 days ago

Analyst Report: GSK plc

GSK Surges 8% After Bumping Its 2031 Outlook To North Of $50 Billion
GSK

Investor's Business Daily

17 days ago

GSK Surges 8% After Bumping Its 2031 Outlook To North Of $50 Billion

GSK Stock Jumps on Long-Term Outlook Boost, $2.5B Share Buyback Plan
GSK

Investopedia

17 days ago

GSK Stock Jumps on Long-Term Outlook Boost, $2.5B Share Buyback Plan

Steady M&A Deals to Begin 2025, Disappointing IPOs So Far
GSK

GuruFocus.com

17 days ago

Steady M&A Deals to Begin 2025, Disappointing IPOs So Far

GSK Surges 7% After Bumping Its 2031 Outlook To North Of $50 Billion
GSK

Investor's Business Daily

17 days ago

GSK Surges 7% After Bumping Its 2031 Outlook To North Of $50 Billion

GSK Q4 Earnings: Revenue And EPS Beat, Initiates $2.5 Billion Stock Buyback, Raises Long-Term Annual Sales Forecast To Over $50 Billion
GSK

Benzinga

17 days ago

GSK Q4 Earnings: Revenue And EPS Beat, Initiates $2.5 Billion Stock Buyback, Raises Long-Term Annual Sales Forecast To Over $50 Billion

GSK (GSK) Tops Q4 Earnings and Revenue Estimates
GSK

Zacks

17 days ago

GSK (GSK) Tops Q4 Earnings and Revenue Estimates

GSK Lifts Long-Term Outlook on Drug Pipeline, Buys Back Shares
GSK

Bloomberg

17 days ago

GSK Lifts Long-Term Outlook on Drug Pipeline, Buys Back Shares

RFK Jr. Clears A Key Hurdle To Head Up HHS. Why His Nomination Is A Biotech Black Box.
GSK

Investor's Business Daily

18 days ago

RFK Jr. Clears A Key Hurdle To Head Up HHS. Why His Nomination Is A Biotech Black Box.

Earnings Preview: GSK (GSK) Q4 Earnings Expected to Decline
GSK

Zacks

24 days ago

Earnings Preview: GSK (GSK) Q4 Earnings Expected to Decline

GSK announces EMA accepted for review the MAA for depemokimab
GSK

TipRanks

24 days ago

GSK announces EMA accepted for review the MAA for depemokimab

The RFK Jr. Effect: Biotech Stocks Brace For 'Games' In Senate Hearings
GSK

Investor's Business Daily

24 days ago

The RFK Jr. Effect: Biotech Stocks Brace For 'Games' In Senate Hearings

Europe Drug Regulator Expands GSK's Jemperli/Chemo Combo To Adult Patients With Advanced Endometrial Cancer
GSK

Benzinga

a month ago

Europe Drug Regulator Expands GSK's Jemperli/Chemo Combo To Adult Patients With Advanced Endometrial Cancer

Is GSK plc (GSK) an Undervalued Defensive Stock for 2025?
GSK

Insider Monkey

a month ago

Is GSK plc (GSK) an Undervalued Defensive Stock for 2025?

Ozempic, Xtandi among next 15 drugs selected for U.S. price talks
GSK

TipRanks

a month ago

Ozempic, Xtandi among next 15 drugs selected for U.S. price talks

Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations
GSK

Yahoo Finance

a month ago

Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations

Is GSK plc (GSK) One of the Cheapest Stocks with Biggest Upside Potential?
GSK

Insider Monkey

a month ago

Is GSK plc (GSK) One of the Cheapest Stocks with Biggest Upside Potential?

Healthcare M&A poised for a rebound in 2025
GSK

Yahoo Finance Video

a month ago

Healthcare M&A poised for a rebound in 2025

GSK CEO on US Expansion, M&A, Drug Pipeline, Trump
GSK

Bloomberg

a month ago

GSK CEO on US Expansion, M&A, Drug Pipeline, Trump

Moderna cuts sales forecast on weaker vaccine demand
GSK

Yahoo Finance

a month ago

Moderna cuts sales forecast on weaker vaccine demand

GSK Enters Agreement to Acquire IDRx, Inc.
GSK

Business Wire

a month ago

GSK Enters Agreement to Acquire IDRx, Inc.

Why Is GSK plc (NYSE:GSK) Among the Best FTSE Dividend Stocks to Buy Now?
GSK

Insider Monkey

2 months ago

Why Is GSK plc (NYSE:GSK) Among the Best FTSE Dividend Stocks to Buy Now?

GSK’s Nucala Gains Approval in China for CRSwNP
GSK

TipRanks

2 months ago

GSK’s Nucala Gains Approval in China for CRSwNP

GSK's Sinus Disease Drug Secures Approval In China
GSK

Benzinga

2 months ago

GSK's Sinus Disease Drug Secures Approval In China

Can GSK plc (LON:GSK) Maintain Its Strong Returns?
GSK

Simply Wall St.

2 months ago

Can GSK plc (LON:GSK) Maintain Its Strong Returns?

GSK announces CHMP of the EMA recommended expanding approval of Jemperli
GSK

TipRanks

2 months ago

GSK announces CHMP of the EMA recommended expanding approval of Jemperli

GSK announces FDA granted BTD for Jemperli
GSK

TipRanks

2 months ago

GSK announces FDA granted BTD for Jemperli

GSK’s lung cancer therapy gains EMA PRIME designation
GSK

Pharmaceutical Technology

2 months ago

GSK’s lung cancer therapy gains EMA PRIME designation

GSK's Blood Cancer Drug Shows Improved Survival Compared To Johnson & Johnson's Darzalex
GSK

Benzinga

2 months ago

GSK's Blood Cancer Drug Shows Improved Survival Compared To Johnson & Johnson's Darzalex

Belantamab Mafodotin shows significant overall survival benefit, reducing the risk of death by 42% in multiple myeloma at or after first relapse
GSK

Business Wire

2 months ago

Belantamab Mafodotin shows significant overall survival benefit, reducing the risk of death by 42% in multiple myeloma at or after first relapse

GSK (LON:GSK) investors are sitting on a loss of 3.4% if they invested five years ago
GSK

Simply Wall St.

3 months ago

GSK (LON:GSK) investors are sitting on a loss of 3.4% if they invested five years ago

GSK

Morningstar Research

3 months ago

Analyst Report: GSK plc

GSK gains approval in Japan for extended indication of RSV vaccine
GSK

Pharmaceutical Technology

3 months ago

GSK gains approval in Japan for extended indication of RSV vaccine

GSK announces Japan’s MHLW approved application to extend indication of Arexvy
GSK

TipRanks

3 months ago

GSK announces Japan’s MHLW approved application to extend indication of Arexvy

GSK's Investigational Liver Disease Candidate Hits Primary Goal In Late-Stage Study To Treat Relentless Itch In Some Patients
GSK

Benzinga

3 months ago

GSK's Investigational Liver Disease Candidate Hits Primary Goal In Late-Stage Study To Treat Relentless Itch In Some Patients

Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer
GSK

GlobeNewswire

3 months ago

Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer

GSK

Morningstar Research

3 months ago

Analyst Report: GSK plc

How analysts are reacting to RFK Jr. as Trump's HHS pick
GSK

Yahoo Finance Video

3 months ago

How analysts are reacting to RFK Jr. as Trump's HHS pick

Trump looks to end EV credit, vaccine stocks fall on RFK JR. pick
GSK

Yahoo Finance Video

3 months ago

Trump looks to end EV credit, vaccine stocks fall on RFK JR. pick

Analysts think Wall Street's reaction to the RFK Jr. news is 'overdone.' Sort of.
GSK

Yahoo Finance

3 months ago

Analysts think Wall Street's reaction to the RFK Jr. news is 'overdone.' Sort of.

Heard on the Street: RFK Jr. Is Spooking Obesity Investors Too
GSK

The Wall Street Journal

3 months ago

Heard on the Street: RFK Jr. Is Spooking Obesity Investors Too

Trump’s RFK Jr. Pick Weighs on Vaccine Makers
GSK

The Wall Street Journal

3 months ago

Trump’s RFK Jr. Pick Weighs on Vaccine Makers

Stocks to Watch Friday: Alibaba, Domino's, Palantir, Ulta Beauty
GSK

The Wall Street Journal

3 months ago

Stocks to Watch Friday: Alibaba, Domino's, Palantir, Ulta Beauty

RFK Jr. News Hits Global Pharma Stocks
GSK

The Wall Street Journal

3 months ago

RFK Jr. News Hits Global Pharma Stocks

European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department
GSK

The Wall Street Journal

3 months ago

European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department

Moderna, Novavax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official
GSK

Yahoo Finance

3 months ago

Moderna, Novavax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official

Moderna, Novovax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official
GSK

Yahoo Finance

3 months ago

Moderna, Novovax stocks slide after Trump nominates Robert F. Kennedy Jr. to be top health official

GSK Raises Prospects For Withdrawn Blood Cancer Drug Blenrep To Return To US Market - Here's Why
GSK

Benzinga

3 months ago

GSK Raises Prospects For Withdrawn Blood Cancer Drug Blenrep To Return To US Market - Here's Why

Regeneron/Sanofi's Dupixent Approval Signals Major Treatment Breakthrough For Smokers' Lung Disease
GSK

Benzinga

3 months ago

Regeneron/Sanofi's Dupixent Approval Signals Major Treatment Breakthrough For Smokers' Lung Disease

Health Canada approves GSK’s Ojjaara for myelofibrosis in anaemia patients
GSK

Pharmaceutical Technology

3 months ago

Health Canada approves GSK’s Ojjaara for myelofibrosis in anaemia patients

GSK

Argus Research

3 months ago

Analyst Report: GSK PLC

GSK

Argus Research

3 months ago

Market Update: GSK, HIG, HLF, MSI, AXON

AstraZeneca’s China-Fueled Plunge May Be Difficult to Shake Off
GSK

Bloomberg

3 months ago

AstraZeneca’s China-Fueled Plunge May Be Difficult to Shake Off

Moderna Slashes Hefty Premarket Gain With A Beat That's 'Not A Beat'
GSK

Investor's Business Daily

3 months ago

Moderna Slashes Hefty Premarket Gain With A Beat That's 'Not A Beat'

Moderna Surges After Crushing Sales Forecasts, Reiterating Its Outlook
GSK

Investor's Business Daily

3 months ago

Moderna Surges After Crushing Sales Forecasts, Reiterating Its Outlook

GSK’s RSV vaccine approved in Canada for adults aged 50 to 59
GSK

Pharmaceutical Technology

4 months ago

GSK’s RSV vaccine approved in Canada for adults aged 50 to 59

We Think You Can Look Beyond GSK's (LON:GSK) Lackluster Earnings
GSK

Simply Wall St.

4 months ago

We Think You Can Look Beyond GSK's (LON:GSK) Lackluster Earnings

GSK Third Quarter 2024 Earnings: EPS Misses Expectations
GSK

Simply Wall St.

4 months ago

GSK Third Quarter 2024 Earnings: EPS Misses Expectations

AstraZeneca Probe in China Adds to Concerns for Foreign Businesses
GSK

The Wall Street Journal

4 months ago

AstraZeneca Probe in China Adds to Concerns for Foreign Businesses

GSK PLC (GSK) Q3 2024 Earnings Call Highlights: Strong Specialty Medicines Growth Amid Vaccine ...
GSK

GuruFocus.com

4 months ago

GSK PLC (GSK) Q3 2024 Earnings Call Highlights: Strong Specialty Medicines Growth Amid Vaccine ...

GSK

Morningstar Research

4 months ago

Analyst Report: GSK plc

GSK Plummets To 10-Month Low As RSV, Shingles Vaccines Hit The Skids
GSK

Investor's Business Daily

4 months ago

GSK Plummets To 10-Month Low As RSV, Shingles Vaccines Hit The Skids

GSK (GSK) Q3 Earnings Surpass Estimates
GSK

Zacks

4 months ago

GSK (GSK) Q3 Earnings Surpass Estimates

GSK Stock Crumbles As Vaccine Sales Plummet And Miss Expectations
GSK

Investor's Business Daily

4 months ago

GSK Stock Crumbles As Vaccine Sales Plummet And Miss Expectations

GSK's Q3 Earnings Hit By Lower Than Expected Vaccine Sales, Cautions Lower Revenue For 2024
GSK

Benzinga

4 months ago

GSK's Q3 Earnings Hit By Lower Than Expected Vaccine Sales, Cautions Lower Revenue For 2024

GSK to acquire CMG1A46 from Chimagen Biosciences
GSK

TipRanks

4 months ago

GSK to acquire CMG1A46 from Chimagen Biosciences

GSK Cuts Vaccine Sales Outlook Amid U.S. Weakness
GSK

The Wall Street Journal

4 months ago

GSK Cuts Vaccine Sales Outlook Amid U.S. Weakness

GSK to acquire Chimagen’s CMG1A46 for autoimmune disease
GSK

Pharmaceutical Technology

4 months ago

GSK to acquire Chimagen’s CMG1A46 for autoimmune disease

GSK

GuruFocus.com

4 months ago

GlaxoSmithKline Pharmaceuticals Ltd (BOM:500660) Q2 2024 Earnings Call Highlights: Revenue ...

Carmakers’ Malaise, UBS’s Next Step: EMEA Earnings Week Ahead
GSK

Bloomberg

4 months ago

Carmakers’ Malaise, UBS’s Next Step: EMEA Earnings Week Ahead

Just After Pfizer's RSV Vaccine Approval For Younger Adults, GSK Layouts Encouraging Preliminary Data Showing Potential For Use In Larger Population
GSK

Benzinga

4 months ago

Just After Pfizer's RSV Vaccine Approval For Younger Adults, GSK Layouts Encouraging Preliminary Data Showing Potential For Use In Larger Population

New Data for AREXVY, GSK’s Respiratory Syncytial Virus Vaccine, Show Potential to Help Protect a Broader Group of Adults at Increased Risk for RSV Disease
GSK

Business Wire

4 months ago

New Data for AREXVY, GSK’s Respiratory Syncytial Virus Vaccine, Show Potential to Help Protect a Broader Group of Adults at Increased Risk for RSV Disease

FDA Approves Pfizer's Respiratory Syncytial Virus Vaccine Abrysvo For Adults Below 60 Years
GSK

Benzinga

4 months ago

FDA Approves Pfizer's Respiratory Syncytial Virus Vaccine Abrysvo For Adults Below 60 Years

Analysts Estimate GSK (GSK) to Report a Decline in Earnings: What to Look Out for
GSK

Zacks

4 months ago

Analysts Estimate GSK (GSK) to Report a Decline in Earnings: What to Look Out for

Korro Bio Is Lagging Wave Life Sciences In RNA Editing. Why It Could Ultimately Lead The Space.
GSK

Investor's Business Daily

4 months ago

Korro Bio Is Lagging Wave Life Sciences In RNA Editing. Why It Could Ultimately Lead The Space.

GSK Seeks FDA Approval For Oral Antibiotic For Urinary Tract Infections, Probably First In New Class In Over 20 Years
GSK

Benzinga

4 months ago

GSK Seeks FDA Approval For Oral Antibiotic For Urinary Tract Infections, Probably First In New Class In Over 20 Years

GSK sues Moderna for US patent infringement over COVID, RSV vaccines
GSK

Reuters

4 months ago

GSK sues Moderna for US patent infringement over COVID, RSV vaccines

Stocks to Watch Monday: Boeing, SoFi, Sirius XM, MicroStrategy
GSK

The Wall Street Journal

4 months ago

Stocks to Watch Monday: Boeing, SoFi, Sirius XM, MicroStrategy

GSK Says Depemokimab For Chronic Rhinosinusitis Reduces Nasal Polyp Size, Nasal Obstruction Versus Placebo At One Year
GSK

Benzinga

4 months ago

GSK Says Depemokimab For Chronic Rhinosinusitis Reduces Nasal Polyp Size, Nasal Obstruction Versus Placebo At One Year

Jim Cramer Says GSK plc (GSK) ‘Goes Higher’
GSK

Insider Monkey

4 months ago

Jim Cramer Says GSK plc (GSK) ‘Goes Higher’

GSK

Morningstar Research

4 months ago

Analyst Report: GSK plc

GSK Shares Climb on $2.2 Billion Zantac Lawsuit Settlement
GSK

The Wall Street Journal

4 months ago

GSK Shares Climb on $2.2 Billion Zantac Lawsuit Settlement

GSK Rises After Settling Zantac Cases for Up to $2.2 Billion
GSK

Bloomberg

4 months ago

GSK Rises After Settling Zantac Cases for Up to $2.2 Billion

Why GSK Stock Rocketed Nearly 6% Skyward on Wednesday
GSK

Motley Fool

4 months ago

Why GSK Stock Rocketed Nearly 6% Skyward on Wednesday

GSK to Pay Over $2 Billion in Bid to End Most U.S. Zantac Lawsuits
GSK

The Wall Street Journal

4 months ago

GSK to Pay Over $2 Billion in Bid to End Most U.S. Zantac Lawsuits

Share on Social Networks: